RecruitingNot ApplicableNCT05267184

Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma

Sponsor

Region Skane

Enrollment

288 participants

Start Date

Mar 28, 2022

Study Type

INTERVENTIONAL

Conditions

Chronic Subdural Hematoma

Summary

The SWEMMA trial is an open, national, multi-center, prospective, randomized (1:1), superiority trial designed to assess impact on reoperation rates for chronic subdural hematoma with a head-to-head comparison of embolization of the middle meningeal artery (intervention) with standard neurosurgical hematoma evacuation (control).

Eligibility

Min Age: 18 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Endovascular treatment of the middle meningeal artery and a procedure called Standard neurosurgical hematoma evacuation for people with chronic subdural hematoma. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years to 89 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndovascular treatment of the middle meningeal artery

The middle meningeal artery on the same side(s) as the chronic subdural hematoma is embolized with liquid embolic agents.

PROCEDUREStandard neurosurgical hematoma evacuation

Standard neurosurgical evacuation of chronic subdural hematoma through burr-hole or mini craniotomy and postoperative subdural or subgaleal drainage.

Locations(4)

Sahlgenska University Hospital

Gothenburg, Sweden

Skåne University Hospital

Lund, Sweden

Karolinska Hospital

Stockholm, Sweden

Norrlands Universitetssjukhus

Umeå, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05267184

Related Trials

A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial

NCT077402391 location

The CHALLENGER Registry

NCT071978401 location

Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)

NCT072452641 location

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

NCT067727401 location

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas

NCT077156561 location